Gynecologic Oncology

Archives of Gynecology and Obstetrics

, Volume 289, Issue 3, pp 663-670

Supplemental screening ultrasound increases cancer detection yield in BRCA1 and BRCA2 mutation carriers

  • Kristin BosseAffiliated withCenter for Familial Breast and Ovarian Cancer, University Hospital of Cologne
  • , Monika GraeserAffiliated withCenter for Familial Breast and Ovarian Cancer, University Hospital of Cologne
  • , Axel GoßmannAffiliated withRadiologische Klinik Merheim
  • , Matthias HackenbrochAffiliated withDepartment for Radiology, University of Cologne
  • , Rita K. SchmutzlerAffiliated withCenter for Familial Breast and Ovarian Cancer, University Hospital of Cologne
  • , Kerstin RhiemAffiliated withCenter for Familial Breast and Ovarian Cancer, University Hospital of Cologne Email author 

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access

Abstract

Introduction

This study aimed at evaluating the efficacy of ultrasound for the early detection of breast cancers in BRCA1/2 mutation carriers.

Methods

Between 01/1997 and 10/2008 221 BRCA1/2 mutation carriers participated in a breast cancer screening program which included semi-annual ultrasound in combination with annual mammography and magnetic resonance imaging (MRI). Women underwent on average (median) five semi-annual screening rounds with a range of one to 22 appointments, totaling 1,855 rounds of screening. All three imaging modalities were coded according to the American College of Radiology (BI-RADS classification).

Results

In total, we detected 27 BRCA-associated breast cancers in 25 patients. The sensitivity was 77 % for ultrasound, 27 % for mammography, and 100 % for MRI. Three tumors were detected directly as a result of only the semi-annual ultrasound screen.

Conclusions

Due to the specific tumor morphology and the considerably elevated tumor doubling time, mutation carriers benefit from the addition of semi-annual ultrasound screening as a sensitive and cost-effective method.

Keywords

Breast cancer BRCA1/2 mutation carriers Ultrasound